Fig. 1 · Structure
Documents & Downloads
Anecortave desacetate
Angiogenesis Inhibitor
Anecortave desacetate is an angiogenesis inhibitor primarily targeting vascular endothelial growth factor (VEGF) pathways. It is utilized in the research of exudative (wet) age-related macular degeneration and retinal tumors, providing insights into the mechanisms of abnormal blood vessel growth. This compound is significant for studies aimed at understanding and mitigating ocular diseases associated with vascular proliferation.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 10184-70-0 |
| Applications | Angiogenesis Inhibitor |
| Formula | C21H28O4 |
| Molecular Weight | 344.44 |
| Synonyms | AL-4940 |
| SMILES | C[C@]12CCC(C=C1CC[C@@H]3C2=CC[C@]4([C@H]3CC[C@@]4(C(CO)=O)O)C)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.